A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment
Clinical trial NCT03069365 · COMPLETED
Trial details
- NCT number
- NCT03069365
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-28
- Primary completion
- 2018-02-20
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.